Related Experiment Videos
In vitro effects of trace elements on blood clotting and platelet function. A--Iron, copper, and gold
E A Abou-Shady1, H E Farrag, N A el-Damarawy
1Dept of Physiology, Faculty of Medicine, Ain Shams University, Cairo, Egypt.
The Journal of the Egyptian Public Health Association
|January 1, 1991
Summary
Iron, copper, and gold salts inhibit blood coagulation and platelet aggregation in vitro. These metals affect clotting factors and fibrinogen function, impacting hemostasis.
Area of Science:
- Hematology
- Toxicology
- Biochemistry
Background:
- Blood coagulation is a complex process involving platelets and plasma proteins.
- Disruptions in hemostasis can lead to bleeding disorders or thrombosis.
- The in vitro effects of metal ions on coagulation are not fully understood.
Purpose of the Study:
- To investigate the in vitro effects of ferrous sulfate, copper sulfate, and gold chloride on rat blood coagulation and platelet function.
- To determine the dose-dependency and mechanisms of action of these metal ions on hemostasis.
Main Methods:
- In vitro study using pooled rat plasma and platelet-rich plasma (PRP).
- Assessed effects on clotting parameters (e.g., thrombin time, fibrinogen clotting time).
- Evaluated platelet aggregation in response to ADP and collagen.
- Examined interactions with thrombin and fibrinogen.
Main Results:
- Ferrous sulfate inhibited coagulation and dose-dependently reduced platelet aggregation.
- Copper sulfate showed anticoagulant effects, inhibited platelet aggregation, and minimally affected fibrinogen.
- Gold chloride prolonged clotting times, inhibited platelet aggregation, and demonstrated antithrombin activity.
Conclusions:
- Iron, copper, and gold ions can significantly interfere with blood coagulation and platelet aggregation in vitro.
- These metals exhibit varying mechanisms, including effects on thrombin activity and fibrinogen function.
- Further research is needed to understand the in vivo implications of these findings.